Total Payments
$28,476
2024 Payments
$546.78
Companies
17
Transactions
88
Medicare Patients
6,194
Medicare Billing
$1.1M
Payment Breakdown by Category
Other$24,975 (87.7%)
Food & Beverage$2,463 (8.7%)
Travel$1,009 (3.5%)
Education$28.22 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Long term medical supply or device loan | $24,975 | 1 | 87.7% |
| Food and Beverage | $2,463 | 82 | 8.7% |
| Travel and Lodging | $1,009 | 4 | 3.5% |
| Education | $28.22 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BrainScope Company, Inc. | $24,992 | 2 | $0 (2022) |
| Medtronic, Inc. | $1,851 | 25 | $0 (2023) |
| Medtronic USA, Inc. | $518.78 | 26 | $0 (2020) |
| Microtransponder, Inc. | $284.39 | 3 | $0 (2024) |
| ABBVIE INC. | $235.69 | 9 | $0 (2024) |
| Allergan, Inc. | $126.45 | 7 | $0 (2022) |
| Penumbra, Inc. | $108.55 | 1 | $0 (2024) |
| Abbott Laboratories | $100.62 | 1 | $0 (2024) |
| PFIZER INC. | $58.87 | 4 | $0 (2024) |
| Merz Pharmaceuticals, LLC | $48.44 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $546.78 | 12 | Microtransponder, Inc. ($163.66) |
| 2023 | $342.64 | 10 | Microtransponder, Inc. ($120.73) |
| 2022 | $26,568 | 19 | BrainScope Company, Inc. ($24,992) |
| 2021 | $371.96 | 13 | Medtronic, Inc. ($323.91) |
| 2020 | $278.96 | 17 | Medtronic USA, Inc. ($189.82) |
| 2019 | $367.28 | 17 | Medtronic USA, Inc. ($328.96) |
All Payment Transactions
88 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $16.46 | General |
| Category: PAIN | ||||||
| 11/14/2024 | REVANCE THERAPEUTICS, INC. | DAXXIFY (Drug) | Food and Beverage | In-kind items and services | $19.58 | General |
| Category: AESTHETICS AND THERAPEUTICS | ||||||
| 11/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $15.66 | General |
| Category: PAIN | ||||||
| 10/24/2024 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $163.66 | General |
| 07/25/2024 | Penumbra, Inc. | Real Immersive System (Device) | Food and Beverage | Cash or cash equivalent | $108.55 | General |
| Category: Neuro Rehabilitation | ||||||
| 07/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $18.07 | General |
| Category: NEUROSCIENCE | ||||||
| 06/14/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.55 | General |
| Category: NEUROSCIENCE | ||||||
| 06/05/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.08 | General |
| Category: PAIN | ||||||
| 05/30/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $31.33 | General |
| Category: NEUROSCIENCE | ||||||
| 05/02/2024 | Abbott Laboratories | OCTRODE (Device) | Food and Beverage | In-kind items and services | $100.62 | General |
| Category: Neuromodulation | ||||||
| 03/20/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $19.55 | General |
| Category: NEUROSCIENCE | ||||||
| 03/07/2024 | PFIZER INC. | NURTEC ODT (Drug) | Food and Beverage | In-kind items and services | $13.67 | General |
| Category: PAIN | ||||||
| 12/14/2023 | AbbVie Inc. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $29.91 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $25.54 | General |
| 12/04/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2023 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $51.30 | General |
| Category: Drug Infusion Systems | ||||||
| 10/25/2023 | Microtransponder, Inc. | — | Food and Beverage | Cash or cash equivalent | $95.19 | General |
| 10/23/2023 | Scilex Pharmaceuticals Inc. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.05 | General |
| Category: Analgesic | ||||||
| 07/10/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $13.74 | General |
| Category: NEUROLOGY | ||||||
| 05/10/2023 | Merz Pharmaceuticals, LLC | Xeomin (Biological) | Food and Beverage | In-kind items and services | $24.66 | General |
| Category: Musculoskeletal | ||||||
| 04/26/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $30.05 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 02/24/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $33.93 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 12/04/2022 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $60.78 | General |
| Category: Drug Infusion Systems | ||||||
| 12/04/2022 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $12.38 | General |
| Category: Drug Infusion Systems | ||||||
| 12/03/2022 | Medtronic, Inc. | SYNCHROMEDII (Device) | Food and Beverage | In-kind items and services | $13.06 | General |
| Category: Drug Infusion Systems | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 24 | 802 | 24,224 | $794,476 | $275,044 |
| 2022 | 18 | 1,788 | 12,373 | $625,081 | $304,555 |
| 2021 | 14 | 1,988 | 3,827 | $579,572 | $278,023 |
| 2020 | 13 | 1,616 | 3,833 | $720,645 | $278,306 |
Total Patients
6,194
Total Services
44,257
Medicare Billing
$1.1M
Procedure Codes
75
All Medicare Procedures & Services
75 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| J0586 | Injection, abobotulinumtoxina, 5 units | Office | 2023 | 25 | 14,880 | $267,840 | $92,296 | 34.5% |
| J0588 | Injection, incobotulinumtoxin a, 1 unit | Office | 2023 | 17 | 6,150 | $60,748 | $23,965 | 39.4% |
| 90837 | Psychotherapy, 1 hour | Office | 2023 | 22 | 180 | $54,040 | $18,519 | 34.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 81 | 193 | $50,536 | $18,312 | 36.2% |
| 99426 | Principal care management services for a single high-risk disease, first 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 84 | 342 | $44,379 | $15,843 | 35.7% |
| 99427 | Principal care management services for a single high-risk disease, each additional 30 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 83 | 336 | $33,523 | $11,820 | 35.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 81 | 184 | $33,703 | $11,770 | 34.9% |
| 64644 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, first extremity | Office | 2023 | 22 | 75 | $27,156 | $9,752 | 35.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 77 | 77 | $25,482 | $9,705 | 38.1% |
| 92507 | Treatment of speech, language, voice, communication, and/or hearing processing disorder | Office | 2023 | 15 | 140 | $22,858 | $8,093 | 35.4% |
| 97530 | Therapy procedure using functional activities | Office | 2023 | 21 | 298 | $23,795 | $6,994 | 29.4% |
| 97110 | Therapy procedure using exercise to develop strength, endurance, range of motion, and flexibility, each 15 minutes | Office | 2023 | 23 | 392 | $23,665 | $6,867 | 29.0% |
| 96133 | Evaluation of neuropsychological test, each additional hour | Office | 2023 | 17 | 84 | $18,657 | $6,556 | 35.1% |
| 76942 | Ultrasonic guidance for needle placement | Office | 2023 | 49 | 138 | $18,729 | $6,151 | 32.8% |
| 97535 | Training for self-care or home management, each 15 minutes | Office | 2023 | 13 | 309 | $22,149 | $5,707 | 25.8% |
| 64645 | Injection of chemical for paralysis of nerve muscles on arm or leg, 5 or more muscles, each additional extremity | Office | 2023 | 18 | 60 | $15,082 | $5,454 | 36.2% |
| 96132 | Evaluation of neuropsychological test, first hour | Office | 2023 | 37 | 50 | $15,552 | $5,128 | 33.0% |
| 96137 | Administration of psychological or neuropsychological test, each additional 30 minutes | Office | 2023 | 16 | 93 | $8,945 | $2,884 | 32.2% |
| 97112 | Therapy procedure to re-educate brain-to-nerve-to-muscle function, each 15 minutes | Office | 2023 | 12 | 139 | $9,730 | $2,646 | 27.2% |
| 92523 | Evaluation of speech sound production with evaluation of language comprehension and expression | Office | 2023 | 14 | 14 | $6,448 | $2,479 | 38.4% |
| 97166 | Evaluation for occupational therapy, typically 45 minutes | Office | 2023 | 19 | 19 | $3,826 | $1,504 | 39.3% |
| 92060 | Exam to measure eye deviation and range of motion | Office | 2023 | 21 | 27 | $3,574 | $1,257 | 35.2% |
| 96136 | Administration of psychological or neuropsychological test, first 30 minutes | Office | 2023 | 16 | 23 | $2,588 | $774.41 | 29.9% |
| 96138 | Administration of psychological or neuropsychological test by technician, first 30 minutes | Office | 2023 | 19 | 21 | $1,472 | $567.00 | 38.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 445 | 1,780 | $194,020 | $99,232 | 51.1% |
About Dr. Haresh Sampathkumar, MD
Dr. Haresh Sampathkumar, MD is a Brain Injury Medicine healthcare provider based in Dover, Delaware. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/08/2013. The National Provider Identifier (NPI) number assigned to this provider is 1568803575.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Haresh Sampathkumar, MD has received a total of $28,476 in payments from pharmaceutical and medical device companies, with $546.78 received in 2024. These payments were reported across 88 transactions from 17 companies. The most common payment nature is "Long term medical supply or device loan" ($24,975).
As a Medicare-enrolled provider, Sampathkumar has provided services to 6,194 Medicare beneficiaries, totaling 44,257 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 75 distinct procedure/service records.
Ad
Practice Information
- Specialty Brain Injury Medicine
- Other Specialties Physical Medicine & Rehabilitation
- Location Dover, DE
- Active Since 07/08/2013
- Last Updated 02/11/2025
- Taxonomy Code 2081P0301X
- Entity Type Individual
- NPI Number 1568803575
Products in Payments
- BrainScope One (Device) $24,992
- SYNCHROMEDII (Device) $1,527
- VECTRIS (Device) $341.87
- SYNCHROMED (Device) $295.45
- BOTOX (Biological) $219.46
- ASCENDA (Device) $133.56
- Real Immersive System (Device) $108.55
- OCTRODE (Device) $100.62
- UBRELVY (Drug) $79.31
- QULIPTA (Drug) $63.37
- NURTEC ODT (Drug) $58.87
- Xeomin (Biological) $48.44
- INTELLIS (Device) $39.88
- SUBLOCADE (Drug) $28.95
- GABLOFEN (Drug) $28.22
- ON-Q* PUMP AND ACCESSORIES (Device) $24.08
- ZTLido (Drug) $21.05
- DAXXIFY (Drug) $19.58
- SPRINT PNS System (Device) $15.88
- Vanta (Device) $15.72
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.